Photo of Matthew Braddock D.O.

Matthew Braddock, D.O.

ENCORE Borland Groover Clinical Research EBGCR Westside EBGCR Westside Center for Clinical ResearchEncore Borland Groover Clinical Research
810 Lane Avenue South Jacksonville FL 32205 Contact Research: (904) 693-1490

Biography

My philosophy in being a physician is that through prevention and education, my patients and I can work together to achieve their health goals. I try to incorporate this philosophy in my practice and especially in managing chronic diseases. I believe that being involved in clinical research studies helps further our ability to care for a chronically ill patient by providing insights into new and innovative drugs. I am a past department chair for Internal Medicine at St. Vincent’s Medical Center. I have been involved with Westside Center for Clinical Research as a Principal Investigator as well as a sub-Investigator on trials involving diabetes, hyperlipidemia and fatty liver disease.

 

 


EDUCATION: DEGREE:
2005-2009 Chicago College of Osteopathic Medicine DO
of Midwestern University
Downers Grove, IL 

1999-2003 University of North Florida-Undergraduate BS
Jacksonville, FL 

POSTDOCTORIAL TRAINING:

2009-2012 Residency: Serving as chief resident
2011-2012
St. Vincent’s Medical Center
Jacksonville, FL 

CERTIFICATIONS: 

Current active and unrestricted Florida License 

Board Certification Family Medicine through ABMS & AOA

RESEARCH TRAINING:

06/12/2019 Medidata Rave EDC Essentials for Investigators

06/12/2019 Medidata Rave Query Management

01/14/2019 RFMH-A002a- The C-SSRS Training  

01/07/2019 Allergan DDO 3101-301-002 eCOA Training (YPrime)

04/02/2018 InForm 6.1 PI Data Entry  & Signature – Gemphire

01/21/2018 CITI Good Clinical Practice Course

11/19/2016 TransCelerate GCP Certificate 

11/18-19/2016 Clinical Research Training for Physicians sponsored by Encore Research Group 

RESEARCH EXPERIENCE WITH WCCR:

Principal Investigator:

2020-Present Enanta EDP305-102, NASH

2019-Present Next Science CSP-011, Non-Melanoma Skin Cancer Lesions

2019-Present Siemens Centaur-201902.Pro-CATCH-HF

2018-Present Acasti Pharma ACA-CAP-002, Hypertriglyceridemia

2018-2019 Enanta EDP 305-101, NASH

2017-2018 Gemphire Therapeutics GEM-401 (INDIGO-1), Hypertriglyceridemia

Sub-Investigator:

2020-Present GSK 212390, UTI

2019-Present Exact Sciences 2019-01, Colorectal Cancer Screening 

2019-Present Novartis CTQJ230A12001, Lp(a)

2019-Present Sanofi Pasteur MEQ00066, Elderly meningococcal vaccine

2019-Present Novo Nordisk NN9536-4576, Obesity

2019-Present Allergan 3101-309-002 Episodic Migraines, Open Label Ext. 

2019-Present Allergan 3101-301-002 Episodic Migraines 

2018-Present Novo Nordisk NN9536-4378, STEP-5 Weight Loss

2018-Present Novo Nordisk NN9536-4374, STEP-2 Weight Loss/Diabetes

2018-Present GSK 207489 (NTHI MCAT-002), COPD 

2018 Quantum Genomics QGC001-2QG3, HBP 

2018-Present Novo Nordisk NN9536-4373, STEP-1 Weight Loss

2017-2018 Sanofi Pasteur QHD00013, Elderly Flu Vaccine

2017-2018 Novo Nordisk NN8022-4272 SCALE-INSULIN), Weight loss/diabetics

2017-2018 Esperion 1002-047, Lipids

2017-Present KOWA K-877-302, Hypertriglyceridemia

2016-Present Esperion 1002-043, Statin-intolerance

2016-2017 Takeda TMX-67_301, CV Comorbidities, Hyperuricemia & Gout

2016-2018 Amarin AMR-01-01-0019, Hypertriglyceridemia

2016-2018 Novo Nordisk NN5401-4266, Type 2 Diabetes

2016-2017 Sanofi EFC13794, Type 2 Diabetes

2016-Present Novo Nordisk 2211-4232, Type 2 Diabetes

2016-2018 Novo Nordisk NN8022-4274, Obesity

WORK EXPERIENCE:

2016-Present Clinical Investigator

Westside Center for Clinical Research

Jacksonville, FL

2016-Present Attending Physician

Baptist Primary Care

Jacksonville, FL

2012-2016 St. Vincent’s Primary Care, Branan Field 

Middleburg, FL 

2013-2016 Chairman of the Department of Medicine

St. Vincent’s Clay County

2013-2016 MSEC 

St. Vincent’s Clay County

2010-2012 Attending Physician ER

Charlton Memorial Hospital

Folkston, GA

 

PUBLICATIONS: 

Peer Reviewed Journal Articles/ Abstracts

A.M.S Mayer, Carlson, L.A., Braddock, M.T., McCulloch, P.F. Hippocampal C-Fos expression and microglia accumulation in rats exposed to the marine toxin domoic acid.. The Toxicologist 2007 Sep; 96(1): 364.

M.T. Braddock, L.A. Carlson, M.L. Hall, P.F. McCulloch and A.M.S. Mayer.. The effect of the marine toxin domoic acid on hippocampal c-FOS expression and microglia accumulation in rats.. JAOA.2007 Sep; 107(8): 347.

Poster Presentation

Matthew T. Braddock, (2007, October). The effect of the marine toxin domoic acid on hippocampal c-FOS expression and microglia accumulation in rats. Poster presented at : AOA Annual Convention and Scientific Seminar; San Diego, CA.